Skip to main content

Clinical trial CA209358

Non-Comparative, Two-Cohort, Single-Arm, Open-Label, Phase 1/2 Study of Nivolumab (BMS-936558) in Subjects with Virus-Positive and Virus-Negative Solid Tumors

Organ Multiple
Trial status Trial closed for recruitment
Trial type
Interventional with experimental drug
Phase Trial phase 1/2
Academic trial Non
Sponsor BMS - Bristol Myers Squibb int.
EudraCT Identifier 2015-000230-29
Inclusion criteria ECOG 0 or 1
Last update